Related Experiment Video
Updated: May 27, 2025

Viral Nanoparticles for In vivo Tumor Imaging
Published on: November 16, 2012
The roles of plant-derived nanovesicles in malignant tumours: A bibliometric analysis
Dandan Wang1, Zifan Mei1, Tingting Zhao1
1Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University, Chongqing, China.
Abstract:
Malignant tumours remain one of the most intractable health problems worldwide. Recently, plant-derived nanovesicles (PDNVs) have emerged as a promising tool in the treatment of malignant tumours, leveraging their high biosafety and potential mechanisms such as cancer-selective apoptosis induction and cell cycle arrest. This paper presents a systematic review of the research progress of nanovesicles in malignant tumours, with a focus on plant-derived vesicles (PDVs) and their potential applications in cancer treatment, based on bibliometric analysis. In this review, the research on PDNVs in malignant tumours was identified and analysed through various countries/institutions, authors, references and research hotspots. Furthermore, we summarized the diverse biological functions and applications of PDNVs sourced from various origins in malignant tumours, both when acting independently and as carriers. Lastly, we provide an outlook on the potential applications of PDNVs in malignant tumours. The purpose of this paper is to summarize the research progress of the role of PDNVs in malignant tumours, and to provide new ideas and clues for overcoming the difficulties of tumour treatment.
Insights
Plant-derived nanovesicles (PDNVs) show promise for treating malignant tumors due to their safety and ability to induce cancer cell death. This review analyzes research on PDNVs for cancer therapy, offering insights for future treatments.
Area of Science:
- Biotechnology
- Oncology
- Nanomedicine
Background:
- Malignant tumors represent a significant global health challenge.
- Plant-derived nanovesicles (PDNVs) offer a promising, biosafety-conscious approach to cancer treatment.
- PDNVs exhibit mechanisms like cancer-selective apoptosis and cell cycle arrest.
Purpose of the Study:
- To systematically review research progress on nanovesicles in malignant tumors.
- To focus on plant-derived vesicles (PDVs) and their cancer treatment applications via bibliometric analysis.
- To summarize PDNVs' biological functions, applications, and future potential in oncology.
Main Methods:
- Bibliometric analysis of research on PDNVs in malignant tumors.
- Identification and analysis of research trends by country, institution, author, and hotspots.
- Synthesis of data on PDNVs' diverse biological functions and applications.
Main Results:
- Analysis of global research landscape for PDNVs in cancer treatment.
- Summary of PDNVs' roles, both independently and as carriers, in targeting malignant tumors.
- Identification of key research areas and emerging trends in PDNVs for oncology.
Conclusions:
- PDNVs are a significant area of research for novel cancer therapies.
- Further investigation into PDNVs' mechanisms and applications can overcome challenges in tumor treatment.
- This review provides a comprehensive overview and future directions for PDNVs in oncology.
Related Concept Videos
Mesenchymal Stem Cells
The Tumor Microenvironment
Drugs that Stabilize Microtubules
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs that Destabilize Microtubules

